SlideShare una empresa de Scribd logo
1 de 28
Descargar para leer sin conexión
EPIDEMEOLOGY
OF TYPHOID
FEVER
SANNIPATAJ JAWAR
PRESENTED BY
AYUSHI TAYAL
(BATCH -2019)
CONTENTS
INTRODUCTION
PROBLEM STATEMENT
EPIDEMEOLOGICAL DETERMINANTS
CLINICAL FEATURES
LABORATORY DIAGNOSIS OF TYPHOID
CONTROL OF TYPHOID FEVER
AYURVEDIC CONCEPT OF TYPHOID FEVER
WHAT IS TYPHOID FEVER?
• TYPHOID FEVER IS A BACTERIAL INFECTION THAT CAN SPREAD
THROUGHOUT THE BODY, AFFECTING MANY ORGANS.
• RESULT OF SYSTEMIC INFECTION CAUSED BY SALMONELLA TYPHI.
• CLINICALLY CHARACTERIZED BY TYPICAL CONTINUOUS FEVER FOR 3 TO 4
WEEKS, RELATIVELY BRADYCARDIA WITH INVOLVEMENT OF INTESTINAL
LYMPHOID TISSUES AND CONSIDERABLE CONSTITUTIONAL SYMPTOMS.
• "ENTERIC FEVER" INCLUDES BOTH TYPHOID AND PARATYPHOID FEVER.
MAY OCCUR SPORADICALLY, EPIDEMICALLY OR ENDEMICALLY. FOUND
ONLY IN HUMAN.
PROBLEM STATEMENT
GLOBAL
DISEASE BURDEN IS 21 MILLION CASES ANNUALLY, (2,10,00,000 CASES). WITH DEATHS
OF 2,16,000-6,00,000 PER YEAR.
MAJORITY OF THIS BURDEN OCCURS IN ASIA.
INDIA:
TYPHOID FEVER IS ENDEMIC IN INDIA.
DATA SHOWS 1.53 MILLION CASES & 361 DEATHS IN 2013.
WORLD’S LARGEST OUTBREAK OF TYPHOID IN SANGLI ON DEC 1975 TO
FEB 1976
EPIDEMIOLOGICAL DETERMINANTS
• 1. AGENT FACTORS
• 2. HOST FACTORS
• 3. ENVIRONMENTAL & SOCIAL FACTORS
• 4. INCUBATION PERIOD
• 5. MODE OF TRANSMISSION
1 TYPHOID FEVER MAINLY CAUSED BY THE BACTERIUM SALMONELLA
TYPHI FROM THE FAMILY ENTEROBACTERIACEAE.
2 S. TYPHI IS A GRAM-NEGATIVE, FACULTATIVE AEROBIC, NON SPORE
FORMING BACTERIA THAT ISMOTILE DUE TO ITS PERITRICHOUS
FLAGELLA.
3 THE BACTERIA GROWS BEST AT 37 C.
AGENT FACTORS
-
B- RESERVOIR OF INFECTION
HUMAN IS THE ONLY RESERVOIR
1 CASE
• - A CASE IS INFECTIOUS AS LONG AS
BACILLI APPEARS IN STOOLS OR URINE.
• CASE MAY BE MISSED, MILD OR SEVERE.
• 2. CARRIERS
• TEMPORARY/INCUBATORY EXCRETE BACILLI FOR
6 TO 8 WEEKS.
CLINICAL SYMPTOMS ARE NOT SHOWN IN PERSON
,BUT THEY ARE CAPABLE OF TRANSMITTING THE
INFECTION
• CHRONIC CARRIER -EXCRETE BACILLI FOR MORE
THAN A YEAR, ORGANISM PERSIST IN GALL
BLADDER/BILIARY TRACT. . E.G. "TYPHOID
MARRY" REAL NAME MARY MALLON
•
TYPHOID MARY
• MARY MALLON WAS A COOK IN OYSTER BAY, NEW YORK IN EARLY 1900 S
• AS A HEALTHY CARRIER OF SALMONELLA TYPHI HER NICKNAME OF “TYPHOID
MARY” HAD BECOME SYNONYMOUS WITH THE SPREAD OF DISEASE, AS MANY WERE
INFECTED DUE TO HER DENIAL OF BEING ILL
• A COMBINATION OF PEACH ICE CREAM AND MALLON'S POOR
HAND WASHING LIKELY SPARKED TYPHOID FEVER OUTBREAKS
• GAVE RISE TO MORE THAN 1300 CASES IN HER LIFE TIME.
• SHE DIED OF PNEUMONIA AFTER 26 YEARS IN QUARANTINE
C SOURCE OF INFECTION
PRIMARY SOURCES
• FAECES & URINE OF CASES AND
CARRIERS.
• FAECAL CARRIERS ARE MORE
FREQUENT THAN URINARY
CARRIERS
SECONDARY SOURCES
CONTAMINATED
- WATER
- FOOD
- FINGERS
- FLIES
• HOW DOES THE BACTERIA CAUSE DISEASE ?
• INGESTION OF CONTAMINATED FOOD OR WATER SALMONELLA BACTERIA
• INVADE SMALL INTESTINE AND ENTER THE BLOODSTREAM
• CARRIED BY WHITE BLOOD CELLS IN THE LIVER, SPLEEN, AND BONE MARROW
• MULTIPLY AND RE - ENTER THE BLOODSTREAM
• BACTERIA INVADE THE GALLBLADDER, BILIARY SYSTEM, AND THE LYMPHATIC
TISSUE OF THE BOWEL AND MULTIPLY IN HIGH NUMBERS
• THEN PASS INTO THE INTESTINAL TRACT AND CAN BE IDENTIFIED FOR DIAGNOSIS
IN CULTURES FROM THE STOOL TESTED IN THE LABORATORY
2- HOST FACTORS
• (A) AGE- OCCUR AT ANY AGE BUT HIGHEST INCIDENCE IN 5-19 YRS. AGE
GROUP.
• (B) SEX- CASES MORE IN MALES THAN FEMALE
- CARRIER RATE IS MORE IN FEMALES
• (C) IMMUNITY- ANTIBODY MAY BE STIMULATED BY INFECTION OR IMMUNIZATION.
ANTIBODY AGAINST (O) ANTIGEN IS HIGHER IN PATIENT WITH THE DISEASE AND
ANTIBODY AGAINST (H) ANTIGEN IS HIGHER IN IMMUNIZED PERSON. S.TYPHI IS
INTRACELLULAR ORGANISM SO CELL MEDIATED IMMUNITY PLAYS A MAJOR ROLE IN
COMBATING THE INFECTION.
3- ENVIRONMENTAL & SOCIAL FACTORS
TYPHOID FEVER REGARDED AS "INDEX OF GENERAL SANITATION" IN ANY COUNTRY.
• INCREASE INCIDENCE IN JULY-SEPTEMBER.
• OUTSIDE HUMAN BODY BACILLI FOUND IN
ICE & ICE CREAM- OVER A MONTH
WATER-2 TO 7 DAYS BUT NOT MULTIPLY
SOIL IRRIGATED WITH SEWAGE- 35 TO 70 DAYS
FOOD- MULTIPLY & SURVIVE FOR SOMETIME
MILK- GROW RAPIDLY WITHOUT ALTERING ITS TASTE
VEGETABLES GROW IN SEWAGE PLANT.
• POLLUTION OF DRINKING WATER SUPPLIES.
• OPEN AREA DEFECATION & URINATION.
• LOW PERSONAL HYGIENE.
• HEALTH IGNORANCE.
INCUBATION PERIOD
• INCUBATION PERIOD – USUALLY 10-14 DAYS BUT IT MAY BE AS SHORT AS 3 DAYS
OR AS LONG AS 21 DAYS DEPENDING UPON THE DOSE OF BACILLI INGESTED.
SIGNS AND SYMPTOMS
• CLASSICALLY, THE COURSE OF UNTREATED TYPHOID FEVER IS DIVIDED INTO FOUR DISTINCT STAGES, EACH LASTING ABOUT A WEEK.
OVER THE COURSE OF THESE STAGES, THE PATIENT BECOMES EXHAUSTED.
• CLINICAL FEATURES
• INITIAL WEEKS OF THE INFECTION: IN THE FIRST WEEK:
⚫ FEVER IN STEP LADDER FASHION
⚫ RELATIVE BRADYCARDIA, MALAISE,
⚫ HEADACHE
• COUGH, SORE THROAT.
• A BLOODY NOSE (EPISTAXIS) IS SEEN IN A QUARTER OF CASES, AND ABDOMINAL PAIN IS ALSO POSSIBLE WITH CONSTIPATION OR PEA
SOUP DIARRHOEA.
LATER STAGES OF INFECTION
• SERIOUS COMPLICATIONS OCCUR IN UPTO 10% OF CASES, IF ILLNESS PROLONG
BEYOND 2 WEEKS.
• THIRD WEEK: INTESTINAL HAEMORRHAGE AND PERFORATION.
• SIGNS OF SHOCK, SUDDEN DROP IN TEMPERATURE , DARK OR FRESH BLOOD IN
STOOLS.
• • RARE COMPLICATIONS:
• URINE RETENTION, PNEUMONIA, MYOCARDITIS, CHOLECYSTITIS, NEPHRITIS.
LABORATORY DIAGNOSIS
MICROBIOLOGICAL PROCEDURS
SEROLOGICAL PROCEDURS
NEW DIAGNOSTIC TESTS
SEROLOGICAL PROCEDURES
FELIX-WIDAL TEST
MEASURES AGGLUTINATING ANTIBODIES LEVELS AGAINST
O & H ANTIGENS
SERUM AGGLUTININS RAISE ABRUPTLY DURING THE 2ND OR 3RDWEEK
LIMITATIONS OF WIDAL TEST
• TEST HAS MODERATE SENSITIVITY AND SPECIFICITY.
• TEST CAN BE NEGATIVE IN 30% OF CULTURE PROVEN CASES.
• THIS TEST GIVES FALSE POSITIVE RESULTS DUE TO OTHER CLINICAL CONDITIONS.
CONTROL OF TYPHOID FEVER
1. CONTROL OF:
• RESERVOIRS
• CASES
• CARRIERS
2. CONTROL OF SANITATION
3. IMMUNIZATION
• CONTROL OF RESERVOIRS
• IDENTIFICATION, ISOLATION, TREATMENT &
DISINFECTION.
• CONTROL OF CASES:
• EARLY DIAGNOSIS, NOTIFICATION, ISOLATION,
TREATMENT, FOLLOW-UP.
• CONTROL CARRIERS:
• IDENTIFICATION, TREATMENT, SURGERY,
SURVEILLANCE, HEALTH EDUCATION
CONTROL OF CASES AND CARRIERS
• CONTROL OF CASES
• EARLY DIAGNOSIS: BLOOD & STOOL CULTURES ARE
IMP. IN DIAGNOSIS OF THE CASES.
• NOTIFICATION: INFORM THE OFFICIALS.
• ISOLATION: SEPARATE THE PATIENTS TO PREVENT
SPREAD OF INFECTION.
• TREATMENT: DRUG OF CHOICE:
FLUOROQUINOLONES.
• FOLLOW-UP: EXAMINATION OF STOOLS & URINE
FOR 3-4 MONTHS AFTER DISCHARGE.
• CONTROL OF CARRIERS
• IDENTIFICATION: TO PREVENT ULTIMATE SOURCE -
TYPHOID.
• TREATMENT: AMPICILLIN OR AMOXYCILLIN WITH
PROBENECID FOR 6 WEEKS.
• SURGERY: CHOLECYSTECTOMY, NEPHRECTOMY CAN BE
DONE.
• SURVEILLANCE: CARRIERS TO BE PREVENTED FROM
FOOD HANDLING.
• HEALTH EDUCATION: REGARDING HAND WASHING
AND SANITATION , ABOUT PERSONAL HYGIENE.
CONTROL OF SANITATION
• PROTECTION & PURIFICATION OF DRINKING WATER SUPPLIES.
• IMPROVEMENT OF BASIC SANITATION.
• PROMOTION OF FOOD HYGIENE.
• SANITATION COMBINED WITH HEALTH EDUCATION RESULTS IN REDUCTION OF TYPHOID
MORBIDITY
IMMUNIZATION
VACCINATION RECOMMENDED TO:
• ANY PERSON ABOVE 2 YRS OF AGE
• THOSE LIVE IN ENDEMIC AREA
• HOUSEHOLD CONTACTS
• GROUP AT RISK LIKE SCHOOL CHILDREN AND HOSPITAL STAFF ETC.
• THOSE ATTENDING MELAS & YATRAS
THREE TYPES OF VACCINES
1 INJECTABLE TYPHOID VACCINE (TYPHIM -VI, TYPHIVAX)
2. THE LIVE ORAL VACCINE (TYPHORAL)
3. Cl as s i c al v ac c i ne
FACTS OF VACCINES Fo r Ty p h o i d
IMMUNITY LASTS FOR 3 YEARS NEED A BOOSTER after ever y vaccine.
TYPES OF VACCINES
• INJECTABLE TYPHIM -VI VACCINE
• 1. THIS SINGLE-DOSE INJECTABLE
TYPHOID VACCINE, FROM THE
BACTERIAL CAPSULE OF S. TYPHI
STRAIN OF TY21A.
• 2. THIS VACCINE IS RECOMMENDED
FOR USE IN CHILDREN OVER 2 YEARS
OF AGE.
• 3. SUB-CUTANEOUS OR
INTRAMUSCULAR INJECTION
• 4. EFFICACY: 64% -72%
• TYPHORAL VACCINE
• 1. THIS IS A LIVE-ATTENUATED-BACTERIA VACCINE
MANUFACTURED FROM THE TY21A STRAIN OF S. TYPHI.
• 2. THE EFFICACY RATE RANGES FROM 50-80%
• 3. NOT RECOMMENDED FOR USE IN CHILDREN
YOUNGER THAN 6 YEARS OF AGE
• 4. THE COURSE CONSISTS OF ONE CAPSULE ORALLY,
TAKEN AN HOUR BEFORE FOOD WITH A GLASS OF
WATER OR MILK (1STDAY, 3RD DAY & 5TH DAY)
• 5. NO ANTIBIOTIC SHOULD BE TAKEN DURING THIS
PERIOD
lassical vaccine
t is a kille vaccine
o mo e than six month baby
ubcutaneously use
i st ose at six months
econ ose afte fou to six weeks
CORRELATION OF SANNIPATAJ SANTATA
JWARA AND TYPHOID FEVER
(IN ACCORDANCE WITH CHARAK CHIKITSA 3)
• वर्तमान काल में टाईफड्ड (TYPHOID FEVER) का समय 3 सप्ताह का माना जार्ा है। सन्निपार् सन्तर् ज्वर
को TYPHOID FEVER माना जा सकर्ा है। सन्निपार्ज ज्वर में दोष क
े र्ारर्म्य से कफप्रधान, वार्प्रधान,
न्नपत्तप्रधान ये ३ प्रकार होर्े हैं। कफ में 'अत्यर्त शीर्न्नपडका भृशमङ्ग
े भ्य उन्नत्तष्ठन्तन्त यह बार् न्ननयानस्र्ान में
बर्ाई गई है। कफ का वर्त श्वेर् होर्ा है। इसन्नलए ये न्नपन्नडकाएँ भी श्वेर् वर्त की होोंगी। टाईफाइड में श्वेर् वर्त
की न्नपन्नडका न्ननकलर्ी है।
EPIDEMEOLOGY OF TYPHOID FEVER.pdf

Más contenido relacionado

Similar a EPIDEMEOLOGY OF TYPHOID FEVER.pdf

Typhoid fever ppt
Typhoid fever pptTyphoid fever ppt
Typhoid fever ppt
Anwar Ahmad
 

Similar a EPIDEMEOLOGY OF TYPHOID FEVER.pdf (20)

Typhoid Fever
Typhoid Fever Typhoid Fever
Typhoid Fever
 
Abortion presentation of obstetrics and gynecological nursing
Abortion presentation of obstetrics and gynecological nursingAbortion presentation of obstetrics and gynecological nursing
Abortion presentation of obstetrics and gynecological nursing
 
Bacterial infection, food borne bacterial infection
Bacterial infection, food borne bacterial infectionBacterial infection, food borne bacterial infection
Bacterial infection, food borne bacterial infection
 
01 09-2017 gut microbiology
01 09-2017 gut microbiology01 09-2017 gut microbiology
01 09-2017 gut microbiology
 
Typhoid fever ppt
Typhoid fever pptTyphoid fever ppt
Typhoid fever ppt
 
AEFI
AEFIAEFI
AEFI
 
Cholera
CholeraCholera
Cholera
 
bacterial food borne disease
bacterial food borne diseasebacterial food borne disease
bacterial food borne disease
 
Epidemiology of Cholera
Epidemiology of CholeraEpidemiology of Cholera
Epidemiology of Cholera
 
Typhoid fever
Typhoid feverTyphoid fever
Typhoid fever
 
Typhoid Final.pptx
Typhoid Final.pptxTyphoid Final.pptx
Typhoid Final.pptx
 
cholera
choleracholera
cholera
 
C.JEJUNI.pptx, ZOONOTIC DISEASES, MEDICAL MICROBIOLOGY
C.JEJUNI.pptx, ZOONOTIC DISEASES, MEDICAL MICROBIOLOGYC.JEJUNI.pptx, ZOONOTIC DISEASES, MEDICAL MICROBIOLOGY
C.JEJUNI.pptx, ZOONOTIC DISEASES, MEDICAL MICROBIOLOGY
 
Typhoid
Typhoid Typhoid
Typhoid
 
Enteric fever
Enteric feverEnteric fever
Enteric fever
 
20180305 typhoid fever
20180305 typhoid fever20180305 typhoid fever
20180305 typhoid fever
 
TYPHOID FEVER
TYPHOID FEVERTYPHOID FEVER
TYPHOID FEVER
 
Typhoid
Typhoid  Typhoid
Typhoid
 
Enteric fever
Enteric feverEnteric fever
Enteric fever
 
HSV keratitis
HSV keratitis HSV keratitis
HSV keratitis
 

Más de PriyankaSharma89719

Milk-hygiene-in-relation-to-public-health.pptx
Milk-hygiene-in-relation-to-public-health.pptxMilk-hygiene-in-relation-to-public-health.pptx
Milk-hygiene-in-relation-to-public-health.pptx
PriyankaSharma89719
 
Se Symposium (Nov. 04).pptbvxsadghjkjhff
Se Symposium (Nov. 04).pptbvxsadghjkjhffSe Symposium (Nov. 04).pptbvxsadghjkjhff
Se Symposium (Nov. 04).pptbvxsadghjkjhff
PriyankaSharma89719
 
Food-Safety-Manager-PowerPoint-Slides.pptx
Food-Safety-Manager-PowerPoint-Slides.pptxFood-Safety-Manager-PowerPoint-Slides.pptx
Food-Safety-Manager-PowerPoint-Slides.pptx
PriyankaSharma89719
 
Food handler hygiene.pptxnhvgguikknhgffyuj
Food handler hygiene.pptxnhvgguikknhgffyujFood handler hygiene.pptxnhvgguikknhgffyuj
Food handler hygiene.pptxnhvgguikknhgffyuj
PriyankaSharma89719
 
food_and_toxicity-natural_toxins.pptnhhj
food_and_toxicity-natural_toxins.pptnhhjfood_and_toxicity-natural_toxins.pptnhhj
food_and_toxicity-natural_toxins.pptnhhj
PriyankaSharma89719
 
10.1002-cb.2025Figure20250001.pptx.phgfdssftpt
10.1002-cb.2025Figure20250001.pptx.phgfdssftpt10.1002-cb.2025Figure20250001.pptx.phgfdssftpt
10.1002-cb.2025Figure20250001.pptx.phgfdssftpt
PriyankaSharma89719
 
food-preservation.pptjhgfdsweryuiolkjbvvcc
food-preservation.pptjhgfdsweryuiolkjbvvccfood-preservation.pptjhgfdsweryuiolkjbvvcc
food-preservation.pptjhgfdsweryuiolkjbvvcc
PriyankaSharma89719
 
lecture13.ppthjjjkjjjhhhhkkbbgdsawertuiiol
lecture13.ppthjjjkjjjhhhhkkbbgdsawertuiiollecture13.ppthjjjkjjjhhhhkkbbgdsawertuiiol
lecture13.ppthjjjkjjjhhhhkkbbgdsawertuiiol
PriyankaSharma89719
 
Ch5-Microbial-Food-Safety-Chapt-5.pptnbgfffhx
Ch5-Microbial-Food-Safety-Chapt-5.pptnbgfffhxCh5-Microbial-Food-Safety-Chapt-5.pptnbgfffhx
Ch5-Microbial-Food-Safety-Chapt-5.pptnbgfffhx
PriyankaSharma89719
 
s-357-04.pptbgdsw46iolkhgsaxcbnmlkhgfswety
s-357-04.pptbgdsw46iolkhgsaxcbnmlkhgfswetys-357-04.pptbgdsw46iolkhgsaxcbnmlkhgfswety
s-357-04.pptbgdsw46iolkhgsaxcbnmlkhgfswety
PriyankaSharma89719
 
1586524447FOOD_SAFETY_AND_HYGIENE_MPH_2013-EHS701_(2).ppt
1586524447FOOD_SAFETY_AND_HYGIENE_MPH_2013-EHS701_(2).ppt1586524447FOOD_SAFETY_AND_HYGIENE_MPH_2013-EHS701_(2).ppt
1586524447FOOD_SAFETY_AND_HYGIENE_MPH_2013-EHS701_(2).ppt
PriyankaSharma89719
 
AnyConv.com__FSS Advance Retail & Distribution - 15.06.17.ppt
AnyConv.com__FSS Advance Retail & Distribution - 15.06.17.pptAnyConv.com__FSS Advance Retail & Distribution - 15.06.17.ppt
AnyConv.com__FSS Advance Retail & Distribution - 15.06.17.ppt
PriyankaSharma89719
 
3_Food_Safty_Saxena_MDM.ppt bjjhgcdsdghnnb
3_Food_Safty_Saxena_MDM.ppt bjjhgcdsdghnnb3_Food_Safty_Saxena_MDM.ppt bjjhgcdsdghnnb
3_Food_Safty_Saxena_MDM.ppt bjjhgcdsdghnnb
PriyankaSharma89719
 
Presentation.pptx kohgddsdfhjkoiutrssdghbbvc
Presentation.pptx kohgddsdfhjkoiutrssdghbbvcPresentation.pptx kohgddsdfhjkoiutrssdghbbvc
Presentation.pptx kohgddsdfhjkoiutrssdghbbvc
PriyankaSharma89719
 
vitamins.pdf bhfdrgjkm9hhfdsawryioolljjhgf
vitamins.pdf bhfdrgjkm9hhfdsawryioolljjhgfvitamins.pdf bhfdrgjkm9hhfdsawryioolljjhgf
vitamins.pdf bhfdrgjkm9hhfdsawryioolljjhgf
PriyankaSharma89719
 
171-Careers-Physician.pptnhgfdsswethjioplmnbbvcxd
171-Careers-Physician.pptnhgfdsswethjioplmnbbvcxd171-Careers-Physician.pptnhgfdsswethjioplmnbbvcxd
171-Careers-Physician.pptnhgfdsswethjioplmnbbvcxd
PriyankaSharma89719
 
teez.pptxnjhhfbnkkojhgfdsaqwetyiopllmnvcc
teez.pptxnjhhfbnkkojhgfdsaqwetyiopllmnvccteez.pptxnjhhfbnkkojhgfdsaqwetyiopllmnvcc
teez.pptxnjhhfbnkkojhgfdsaqwetyiopllmnvcc
PriyankaSharma89719
 
HECP-nutrition-and-health-ppt.pptxmjhggghhj
HECP-nutrition-and-health-ppt.pptxmjhggghhjHECP-nutrition-and-health-ppt.pptxmjhggghhj
HECP-nutrition-and-health-ppt.pptxmjhggghhj
PriyankaSharma89719
 

Más de PriyankaSharma89719 (20)

HNVF_StaraPlanina_Hygiene.ppthgfffuuikkbgfd
HNVF_StaraPlanina_Hygiene.ppthgfffuuikkbgfdHNVF_StaraPlanina_Hygiene.ppthgfffuuikkbgfd
HNVF_StaraPlanina_Hygiene.ppthgfffuuikkbgfd
 
Milk-hygiene-in-relation-to-public-health.pptx
Milk-hygiene-in-relation-to-public-health.pptxMilk-hygiene-in-relation-to-public-health.pptx
Milk-hygiene-in-relation-to-public-health.pptx
 
Se Symposium (Nov. 04).pptbvxsadghjkjhff
Se Symposium (Nov. 04).pptbvxsadghjkjhffSe Symposium (Nov. 04).pptbvxsadghjkjhff
Se Symposium (Nov. 04).pptbvxsadghjkjhff
 
Food-Safety-Manager-PowerPoint-Slides.pptx
Food-Safety-Manager-PowerPoint-Slides.pptxFood-Safety-Manager-PowerPoint-Slides.pptx
Food-Safety-Manager-PowerPoint-Slides.pptx
 
Food handler hygiene.pptxnhvgguikknhgffyuj
Food handler hygiene.pptxnhvgguikknhgffyujFood handler hygiene.pptxnhvgguikknhgffyuj
Food handler hygiene.pptxnhvgguikknhgffyuj
 
food_and_toxicity-natural_toxins.pptnhhj
food_and_toxicity-natural_toxins.pptnhhjfood_and_toxicity-natural_toxins.pptnhhj
food_and_toxicity-natural_toxins.pptnhhj
 
10.1002-cb.2025Figure20250001.pptx.phgfdssftpt
10.1002-cb.2025Figure20250001.pptx.phgfdssftpt10.1002-cb.2025Figure20250001.pptx.phgfdssftpt
10.1002-cb.2025Figure20250001.pptx.phgfdssftpt
 
food-preservation.pptjhgfdsweryuiolkjbvvcc
food-preservation.pptjhgfdsweryuiolkjbvvccfood-preservation.pptjhgfdsweryuiolkjbvvcc
food-preservation.pptjhgfdsweryuiolkjbvvcc
 
lecture13.ppthjjjkjjjhhhhkkbbgdsawertuiiol
lecture13.ppthjjjkjjjhhhhkkbbgdsawertuiiollecture13.ppthjjjkjjjhhhhkkbbgdsawertuiiol
lecture13.ppthjjjkjjjhhhhkkbbgdsawertuiiol
 
Ch5-Microbial-Food-Safety-Chapt-5.pptnbgfffhx
Ch5-Microbial-Food-Safety-Chapt-5.pptnbgfffhxCh5-Microbial-Food-Safety-Chapt-5.pptnbgfffhx
Ch5-Microbial-Food-Safety-Chapt-5.pptnbgfffhx
 
s-357-04.pptbgdsw46iolkhgsaxcbnmlkhgfswety
s-357-04.pptbgdsw46iolkhgsaxcbnmlkhgfswetys-357-04.pptbgdsw46iolkhgsaxcbnmlkhgfswety
s-357-04.pptbgdsw46iolkhgsaxcbnmlkhgfswety
 
1586524447FOOD_SAFETY_AND_HYGIENE_MPH_2013-EHS701_(2).ppt
1586524447FOOD_SAFETY_AND_HYGIENE_MPH_2013-EHS701_(2).ppt1586524447FOOD_SAFETY_AND_HYGIENE_MPH_2013-EHS701_(2).ppt
1586524447FOOD_SAFETY_AND_HYGIENE_MPH_2013-EHS701_(2).ppt
 
AnyConv.com__FSS Advance Retail & Distribution - 15.06.17.ppt
AnyConv.com__FSS Advance Retail & Distribution - 15.06.17.pptAnyConv.com__FSS Advance Retail & Distribution - 15.06.17.ppt
AnyConv.com__FSS Advance Retail & Distribution - 15.06.17.ppt
 
3_Food_Safty_Saxena_MDM.ppt bjjhgcdsdghnnb
3_Food_Safty_Saxena_MDM.ppt bjjhgcdsdghnnb3_Food_Safty_Saxena_MDM.ppt bjjhgcdsdghnnb
3_Food_Safty_Saxena_MDM.ppt bjjhgcdsdghnnb
 
Presentation.pptx kohgddsdfhjkoiutrssdghbbvc
Presentation.pptx kohgddsdfhjkoiutrssdghbbvcPresentation.pptx kohgddsdfhjkoiutrssdghbbvc
Presentation.pptx kohgddsdfhjkoiutrssdghbbvc
 
vitamins.pdf bhfdrgjkm9hhfdsawryioolljjhgf
vitamins.pdf bhfdrgjkm9hhfdsawryioolljjhgfvitamins.pdf bhfdrgjkm9hhfdsawryioolljjhgf
vitamins.pdf bhfdrgjkm9hhfdsawryioolljjhgf
 
171-Careers-Physician.pptnhgfdsswethjioplmnbbvcxd
171-Careers-Physician.pptnhgfdsswethjioplmnbbvcxd171-Careers-Physician.pptnhgfdsswethjioplmnbbvcxd
171-Careers-Physician.pptnhgfdsswethjioplmnbbvcxd
 
teez.pptxnjhhfbnkkojhgfdsaqwetyiopllmnvcc
teez.pptxnjhhfbnkkojhgfdsaqwetyiopllmnvccteez.pptxnjhhfbnkkojhgfdsaqwetyiopllmnvcc
teez.pptxnjhhfbnkkojhgfdsaqwetyiopllmnvcc
 
HECP-nutrition-and-health-ppt.pptxmjhggghhj
HECP-nutrition-and-health-ppt.pptxmjhggghhjHECP-nutrition-and-health-ppt.pptxmjhggghhj
HECP-nutrition-and-health-ppt.pptxmjhggghhj
 
4.01C_Nutrients.pptghjnhjknbhggfbhgfdswetuolcvbjkmn
4.01C_Nutrients.pptghjnhjknbhggfbhgfdswetuolcvbjkmn4.01C_Nutrients.pptghjnhjknbhggfbhgfdswetuolcvbjkmn
4.01C_Nutrients.pptghjnhjknbhggfbhgfdswetuolcvbjkmn
 

Último

1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
SoniaTolstoy
 

Último (20)

Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
9548086042 for call girls in Indira Nagar with room service
9548086042  for call girls in Indira Nagar  with room service9548086042  for call girls in Indira Nagar  with room service
9548086042 for call girls in Indira Nagar with room service
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajan
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdf
 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 

EPIDEMEOLOGY OF TYPHOID FEVER.pdf

  • 2. CONTENTS INTRODUCTION PROBLEM STATEMENT EPIDEMEOLOGICAL DETERMINANTS CLINICAL FEATURES LABORATORY DIAGNOSIS OF TYPHOID CONTROL OF TYPHOID FEVER AYURVEDIC CONCEPT OF TYPHOID FEVER
  • 3. WHAT IS TYPHOID FEVER? • TYPHOID FEVER IS A BACTERIAL INFECTION THAT CAN SPREAD THROUGHOUT THE BODY, AFFECTING MANY ORGANS. • RESULT OF SYSTEMIC INFECTION CAUSED BY SALMONELLA TYPHI. • CLINICALLY CHARACTERIZED BY TYPICAL CONTINUOUS FEVER FOR 3 TO 4 WEEKS, RELATIVELY BRADYCARDIA WITH INVOLVEMENT OF INTESTINAL LYMPHOID TISSUES AND CONSIDERABLE CONSTITUTIONAL SYMPTOMS. • "ENTERIC FEVER" INCLUDES BOTH TYPHOID AND PARATYPHOID FEVER. MAY OCCUR SPORADICALLY, EPIDEMICALLY OR ENDEMICALLY. FOUND ONLY IN HUMAN.
  • 4. PROBLEM STATEMENT GLOBAL DISEASE BURDEN IS 21 MILLION CASES ANNUALLY, (2,10,00,000 CASES). WITH DEATHS OF 2,16,000-6,00,000 PER YEAR. MAJORITY OF THIS BURDEN OCCURS IN ASIA. INDIA: TYPHOID FEVER IS ENDEMIC IN INDIA. DATA SHOWS 1.53 MILLION CASES & 361 DEATHS IN 2013. WORLD’S LARGEST OUTBREAK OF TYPHOID IN SANGLI ON DEC 1975 TO FEB 1976
  • 5. EPIDEMIOLOGICAL DETERMINANTS • 1. AGENT FACTORS • 2. HOST FACTORS • 3. ENVIRONMENTAL & SOCIAL FACTORS • 4. INCUBATION PERIOD • 5. MODE OF TRANSMISSION
  • 6. 1 TYPHOID FEVER MAINLY CAUSED BY THE BACTERIUM SALMONELLA TYPHI FROM THE FAMILY ENTEROBACTERIACEAE. 2 S. TYPHI IS A GRAM-NEGATIVE, FACULTATIVE AEROBIC, NON SPORE FORMING BACTERIA THAT ISMOTILE DUE TO ITS PERITRICHOUS FLAGELLA. 3 THE BACTERIA GROWS BEST AT 37 C. AGENT FACTORS -
  • 7. B- RESERVOIR OF INFECTION HUMAN IS THE ONLY RESERVOIR 1 CASE • - A CASE IS INFECTIOUS AS LONG AS BACILLI APPEARS IN STOOLS OR URINE. • CASE MAY BE MISSED, MILD OR SEVERE. • 2. CARRIERS • TEMPORARY/INCUBATORY EXCRETE BACILLI FOR 6 TO 8 WEEKS. CLINICAL SYMPTOMS ARE NOT SHOWN IN PERSON ,BUT THEY ARE CAPABLE OF TRANSMITTING THE INFECTION • CHRONIC CARRIER -EXCRETE BACILLI FOR MORE THAN A YEAR, ORGANISM PERSIST IN GALL BLADDER/BILIARY TRACT. . E.G. "TYPHOID MARRY" REAL NAME MARY MALLON •
  • 8. TYPHOID MARY • MARY MALLON WAS A COOK IN OYSTER BAY, NEW YORK IN EARLY 1900 S • AS A HEALTHY CARRIER OF SALMONELLA TYPHI HER NICKNAME OF “TYPHOID MARY” HAD BECOME SYNONYMOUS WITH THE SPREAD OF DISEASE, AS MANY WERE INFECTED DUE TO HER DENIAL OF BEING ILL • A COMBINATION OF PEACH ICE CREAM AND MALLON'S POOR HAND WASHING LIKELY SPARKED TYPHOID FEVER OUTBREAKS • GAVE RISE TO MORE THAN 1300 CASES IN HER LIFE TIME. • SHE DIED OF PNEUMONIA AFTER 26 YEARS IN QUARANTINE
  • 9. C SOURCE OF INFECTION PRIMARY SOURCES • FAECES & URINE OF CASES AND CARRIERS. • FAECAL CARRIERS ARE MORE FREQUENT THAN URINARY CARRIERS SECONDARY SOURCES CONTAMINATED - WATER - FOOD - FINGERS - FLIES
  • 10. • HOW DOES THE BACTERIA CAUSE DISEASE ? • INGESTION OF CONTAMINATED FOOD OR WATER SALMONELLA BACTERIA • INVADE SMALL INTESTINE AND ENTER THE BLOODSTREAM • CARRIED BY WHITE BLOOD CELLS IN THE LIVER, SPLEEN, AND BONE MARROW • MULTIPLY AND RE - ENTER THE BLOODSTREAM • BACTERIA INVADE THE GALLBLADDER, BILIARY SYSTEM, AND THE LYMPHATIC TISSUE OF THE BOWEL AND MULTIPLY IN HIGH NUMBERS • THEN PASS INTO THE INTESTINAL TRACT AND CAN BE IDENTIFIED FOR DIAGNOSIS IN CULTURES FROM THE STOOL TESTED IN THE LABORATORY
  • 11. 2- HOST FACTORS • (A) AGE- OCCUR AT ANY AGE BUT HIGHEST INCIDENCE IN 5-19 YRS. AGE GROUP. • (B) SEX- CASES MORE IN MALES THAN FEMALE - CARRIER RATE IS MORE IN FEMALES • (C) IMMUNITY- ANTIBODY MAY BE STIMULATED BY INFECTION OR IMMUNIZATION. ANTIBODY AGAINST (O) ANTIGEN IS HIGHER IN PATIENT WITH THE DISEASE AND ANTIBODY AGAINST (H) ANTIGEN IS HIGHER IN IMMUNIZED PERSON. S.TYPHI IS INTRACELLULAR ORGANISM SO CELL MEDIATED IMMUNITY PLAYS A MAJOR ROLE IN COMBATING THE INFECTION.
  • 12. 3- ENVIRONMENTAL & SOCIAL FACTORS TYPHOID FEVER REGARDED AS "INDEX OF GENERAL SANITATION" IN ANY COUNTRY. • INCREASE INCIDENCE IN JULY-SEPTEMBER. • OUTSIDE HUMAN BODY BACILLI FOUND IN ICE & ICE CREAM- OVER A MONTH WATER-2 TO 7 DAYS BUT NOT MULTIPLY SOIL IRRIGATED WITH SEWAGE- 35 TO 70 DAYS FOOD- MULTIPLY & SURVIVE FOR SOMETIME MILK- GROW RAPIDLY WITHOUT ALTERING ITS TASTE VEGETABLES GROW IN SEWAGE PLANT. • POLLUTION OF DRINKING WATER SUPPLIES. • OPEN AREA DEFECATION & URINATION. • LOW PERSONAL HYGIENE. • HEALTH IGNORANCE.
  • 13.
  • 14. INCUBATION PERIOD • INCUBATION PERIOD – USUALLY 10-14 DAYS BUT IT MAY BE AS SHORT AS 3 DAYS OR AS LONG AS 21 DAYS DEPENDING UPON THE DOSE OF BACILLI INGESTED.
  • 15. SIGNS AND SYMPTOMS • CLASSICALLY, THE COURSE OF UNTREATED TYPHOID FEVER IS DIVIDED INTO FOUR DISTINCT STAGES, EACH LASTING ABOUT A WEEK. OVER THE COURSE OF THESE STAGES, THE PATIENT BECOMES EXHAUSTED. • CLINICAL FEATURES • INITIAL WEEKS OF THE INFECTION: IN THE FIRST WEEK: ⚫ FEVER IN STEP LADDER FASHION ⚫ RELATIVE BRADYCARDIA, MALAISE, ⚫ HEADACHE • COUGH, SORE THROAT. • A BLOODY NOSE (EPISTAXIS) IS SEEN IN A QUARTER OF CASES, AND ABDOMINAL PAIN IS ALSO POSSIBLE WITH CONSTIPATION OR PEA SOUP DIARRHOEA.
  • 16. LATER STAGES OF INFECTION • SERIOUS COMPLICATIONS OCCUR IN UPTO 10% OF CASES, IF ILLNESS PROLONG BEYOND 2 WEEKS. • THIRD WEEK: INTESTINAL HAEMORRHAGE AND PERFORATION. • SIGNS OF SHOCK, SUDDEN DROP IN TEMPERATURE , DARK OR FRESH BLOOD IN STOOLS. • • RARE COMPLICATIONS: • URINE RETENTION, PNEUMONIA, MYOCARDITIS, CHOLECYSTITIS, NEPHRITIS.
  • 18. SEROLOGICAL PROCEDURES FELIX-WIDAL TEST MEASURES AGGLUTINATING ANTIBODIES LEVELS AGAINST O & H ANTIGENS SERUM AGGLUTININS RAISE ABRUPTLY DURING THE 2ND OR 3RDWEEK
  • 19. LIMITATIONS OF WIDAL TEST • TEST HAS MODERATE SENSITIVITY AND SPECIFICITY. • TEST CAN BE NEGATIVE IN 30% OF CULTURE PROVEN CASES. • THIS TEST GIVES FALSE POSITIVE RESULTS DUE TO OTHER CLINICAL CONDITIONS.
  • 20. CONTROL OF TYPHOID FEVER 1. CONTROL OF: • RESERVOIRS • CASES • CARRIERS 2. CONTROL OF SANITATION 3. IMMUNIZATION • CONTROL OF RESERVOIRS • IDENTIFICATION, ISOLATION, TREATMENT & DISINFECTION. • CONTROL OF CASES: • EARLY DIAGNOSIS, NOTIFICATION, ISOLATION, TREATMENT, FOLLOW-UP. • CONTROL CARRIERS: • IDENTIFICATION, TREATMENT, SURGERY, SURVEILLANCE, HEALTH EDUCATION
  • 21. CONTROL OF CASES AND CARRIERS • CONTROL OF CASES • EARLY DIAGNOSIS: BLOOD & STOOL CULTURES ARE IMP. IN DIAGNOSIS OF THE CASES. • NOTIFICATION: INFORM THE OFFICIALS. • ISOLATION: SEPARATE THE PATIENTS TO PREVENT SPREAD OF INFECTION. • TREATMENT: DRUG OF CHOICE: FLUOROQUINOLONES. • FOLLOW-UP: EXAMINATION OF STOOLS & URINE FOR 3-4 MONTHS AFTER DISCHARGE. • CONTROL OF CARRIERS • IDENTIFICATION: TO PREVENT ULTIMATE SOURCE - TYPHOID. • TREATMENT: AMPICILLIN OR AMOXYCILLIN WITH PROBENECID FOR 6 WEEKS. • SURGERY: CHOLECYSTECTOMY, NEPHRECTOMY CAN BE DONE. • SURVEILLANCE: CARRIERS TO BE PREVENTED FROM FOOD HANDLING. • HEALTH EDUCATION: REGARDING HAND WASHING AND SANITATION , ABOUT PERSONAL HYGIENE.
  • 22. CONTROL OF SANITATION • PROTECTION & PURIFICATION OF DRINKING WATER SUPPLIES. • IMPROVEMENT OF BASIC SANITATION. • PROMOTION OF FOOD HYGIENE. • SANITATION COMBINED WITH HEALTH EDUCATION RESULTS IN REDUCTION OF TYPHOID MORBIDITY
  • 23. IMMUNIZATION VACCINATION RECOMMENDED TO: • ANY PERSON ABOVE 2 YRS OF AGE • THOSE LIVE IN ENDEMIC AREA • HOUSEHOLD CONTACTS • GROUP AT RISK LIKE SCHOOL CHILDREN AND HOSPITAL STAFF ETC. • THOSE ATTENDING MELAS & YATRAS
  • 24. THREE TYPES OF VACCINES 1 INJECTABLE TYPHOID VACCINE (TYPHIM -VI, TYPHIVAX) 2. THE LIVE ORAL VACCINE (TYPHORAL) 3. Cl as s i c al v ac c i ne FACTS OF VACCINES Fo r Ty p h o i d IMMUNITY LASTS FOR 3 YEARS NEED A BOOSTER after ever y vaccine.
  • 25. TYPES OF VACCINES • INJECTABLE TYPHIM -VI VACCINE • 1. THIS SINGLE-DOSE INJECTABLE TYPHOID VACCINE, FROM THE BACTERIAL CAPSULE OF S. TYPHI STRAIN OF TY21A. • 2. THIS VACCINE IS RECOMMENDED FOR USE IN CHILDREN OVER 2 YEARS OF AGE. • 3. SUB-CUTANEOUS OR INTRAMUSCULAR INJECTION • 4. EFFICACY: 64% -72% • TYPHORAL VACCINE • 1. THIS IS A LIVE-ATTENUATED-BACTERIA VACCINE MANUFACTURED FROM THE TY21A STRAIN OF S. TYPHI. • 2. THE EFFICACY RATE RANGES FROM 50-80% • 3. NOT RECOMMENDED FOR USE IN CHILDREN YOUNGER THAN 6 YEARS OF AGE • 4. THE COURSE CONSISTS OF ONE CAPSULE ORALLY, TAKEN AN HOUR BEFORE FOOD WITH A GLASS OF WATER OR MILK (1STDAY, 3RD DAY & 5TH DAY) • 5. NO ANTIBIOTIC SHOULD BE TAKEN DURING THIS PERIOD
  • 26. lassical vaccine t is a kille vaccine o mo e than six month baby ubcutaneously use i st ose at six months econ ose afte fou to six weeks
  • 27. CORRELATION OF SANNIPATAJ SANTATA JWARA AND TYPHOID FEVER (IN ACCORDANCE WITH CHARAK CHIKITSA 3) • वर्तमान काल में टाईफड्ड (TYPHOID FEVER) का समय 3 सप्ताह का माना जार्ा है। सन्निपार् सन्तर् ज्वर को TYPHOID FEVER माना जा सकर्ा है। सन्निपार्ज ज्वर में दोष क े र्ारर्म्य से कफप्रधान, वार्प्रधान, न्नपत्तप्रधान ये ३ प्रकार होर्े हैं। कफ में 'अत्यर्त शीर्न्नपडका भृशमङ्ग े भ्य उन्नत्तष्ठन्तन्त यह बार् न्ननयानस्र्ान में बर्ाई गई है। कफ का वर्त श्वेर् होर्ा है। इसन्नलए ये न्नपन्नडकाएँ भी श्वेर् वर्त की होोंगी। टाईफाइड में श्वेर् वर्त की न्नपन्नडका न्ननकलर्ी है।